Expertise
Extensive Real-World Expertise and Proficiency
Collectively, RCP brings more than 125 years in rare disease and 30 years in gene therapy of combined global commercialization experience having created new markets and launched 16 products across 17 therapeutic areas.
Our Private Markets practice is uniquely positioned to service our Private Equity and Venture Capital owned clients. Optimized commercial readiness is a path to quickly unlock an organizations potential, drive Time to Value and ultimately have a positive impact to EBITDA.
Extensive Real-World Expertise and Proficiency
Our value comes from the depth and breadth of real-world experience.
Accelerate Your
Commercialization Timeline
Investment in RCP Drives Unprecedented Value
RCP Fees are Small in Comparison to the Typical Commercial Spend

Our Founder and CEO
Christina J. Ansted, MPH, CCMEP is an experienced and multifaceted biotechnology executive with more than twenty years in biotech. She has held roles of increasing leadership and responsibility working across the life cycle of orphan and rare disease assets in a multitude of therapeutic areas including hematology, nephrology, complement inhibition, inherited metabolic diseases, enzyme replacement and gene therapy and has extensive knowledge of broader markets encompassing rheumatoid arthritis, diabetes, obesity, neurology, and psychiatry.


Areas of Subject Matter Expertise
-
Commercial strategy and marketing
-
Market assessment and positioning
-
Shared medical services
-
Investor story/slide deck
-
Investigator/ Key Opinion Leader (KOL) identification and development
-
Patient identification and diagnostics
-
Patient journey
-
Diagnostic landscape analysis
-
Disease awareness and branded campaigns
-
Advisory boards, roundtable meetings and symposia
-
Team development/optimization
Christina’s Experience & Education
Combining her disease experience with an understanding of the complexity of the U.S. and global regions (e.g., EMEAC, LATAM, Asia Pacific) and awareness of the intricate dynamic that exits between affiliates, Christina has been a key player on global teams involved in marketing and launch of new products worldwide. She is well versed in global product commercialization, medical services, and medical communications with expertise in patient identification and diagnostic strategy and integrates this unique perspective to drive sophisticated development of commercial strategy and execution. A results-driven, solution-oriented leader, focused on optimization and outcomes, Christina has a proven record of building exceptional and dedicated teams who work efficiently together in an environment supported by trust and professional respect that become highly productive and drive value across an organization.
Christina has a master’s degree in public health with a concentration in health policy and management from New York Medical College and a bachelor’s degree in biological science with a minor in applied design from The University of Vermont. She is a Certified Continuing Medical Education Professional and has authored publications addressing patient safety and medication errors, mental illness, patient adherence, migraine, multiple sclerosis, rheumatoid arthritis, Alzheimer’s, and Parkinson’s disease. Christina holds a Master Captain license from the United States Coast Guard and lives on the south shore of Massachusetts close to the ocean.
Select Areas of Expertise
